Try
Rhythm Pharmaceuticals Inc. Common Stock
RYTMUnited States
37 filed reports · 389 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
37 reports · Sep 2017 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 27 | 3,148 | Sep 2017 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 9 | 2,882 | Dec 2017 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 1 | Jun 2024 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 4, 2026 | 347 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 200 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 775 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 4, 2025 | 243 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 5, 2025 | 127 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 134 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 28, 2025 | 323 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 6, 2024 | 163 | Open |
| FY2024 Q2 | 10-Q/A | Jun 30, 2024 | Aug 14, 2024 | 1 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 6, 2024 | 123 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 7, 2024 | 115 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 29, 2024 | 341 | Open |
Financial data
389 concepts · 6,031 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial375 concepts · 5,769 facts · Mar 2013 to Aug 2026
- Nonoperating income expense53 · Dec 2015 to Jun 2026
- Profit loss53 · Dec 2015 to Jun 2026
- Operating income loss51 · Dec 2015 to Jun 2026
- Research and development expense51 · Dec 2015 to Jun 2026
- Cash and cash equivalents at carrying value50 · Dec 2015 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities50 · Dec 2015 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets50 · Dec 2015 to Jun 2026
- Net cash provided by used in investing activities50 · Dec 2015 to Jun 2026
- Net cash provided by used in operating activities50 · Dec 2015 to Jun 2026
- Share based compensation50 · Dec 2015 to Jun 2026
- Non-cash rent expense49 · Dec 2016 to Jun 2026
- Proceeds from maturities prepayments and calls of shortterm investments49 · Dec 2016 to Jun 2026
- Selling general and administrative expense49 · Dec 2015 to Jun 2026
- Stockholders equity (US GAAP)49 · Dec 2015 to Jun 2026
- Cash cash equivalents and short term investments48 · Dec 2016 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect48 · Dec 2016 to Jun 2026
- Common stock par or stated value per share48 · Mar 2013 to Jun 2026
- Common stock shares issued48 · Mar 2013 to Jun 2026
- Accounts payable current47 · Dec 2016 to Jun 2026
- Accrued professional fees current47 · Dec 2016 to Jun 2026
- Additional paid in capital47 · Dec 2016 to Jun 2026
- Assets47 · Dec 2016 to Jun 2026
- Assets current47 · Dec 2016 to Jun 2026
- Common stock shares authorized47 · Dec 2016 to Jun 2026
Segment11 concepts · 170 facts · Dec 2022 to Jun 2026
- Revenue66 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)14 · Dec 2022 to Jun 2026
- Interest income expense nonoperating net14 · Dec 2022 to Jun 2026
- Labor and related expense14 · Dec 2022 to Jun 2026
- Single reportable segment14 · Dec 2022 to Jun 2026
- Segment reporting other item amount12 · Dec 2022 to Dec 2025
- Other general expense8 · Dec 2022 to Dec 2025
- Net income loss6 · Mar 2024 to Sep 2025
- Income tax expense benefit4 · Mar 2025 to Jun 2026
- Other nonoperating income expense4 · Mar 2025 to Jun 2026
Product2 concepts · 71 facts · Dec 2016 to Jun 2026
- Revenue65 · Jun 2021 to Jun 2026
- Selling general and administrative expense6 · Dec 2016 to Dec 2021
Geography1 concepts · 21 facts · Dec 2021 to Dec 2024
- Revenue21 · Dec 2021 to Dec 2024
Segments
262 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 170 facts
- Single Reportable170 · Dec 2022 to Jun 2026
Product or service2 members · 71 facts
- Product51 · Jun 2021 to Jun 2026
- License20 · Dec 2016 to Jun 2026
Statement geographical4 members · 21 facts
- US8 · Dec 2021 to Dec 2024
- DE5 · Dec 2022 to Sep 2024
- Other Countries5 · Dec 2022 to Sep 2024
- Non Us3 · Dec 2022 to Dec 2024
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary110 claims from 10 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary141 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes15 claims from 1 reports · Dec 2025
- Risk factors144 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.